Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS , BRAF , NRAS and PIK3CA Genes

Irene Lurkin, Robert Stoehr, Carolyn D. Hurst et al. · 2010

Read Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS , BRAF , NRAS and PIK3CA Genes by Irene Lurkin, Robert Stoehr, Carolyn D. Hurst et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0008802.txt.

Description

Irene Lurkin, Robert Stoehr, Carolyn Hurst, and colleagues built a fast mutation test for cancer care. Their assay study appeared in PLOS ONE in 2010. Some advanced colorectal cancers resist drugs aimed at a growth receptor. Resistance follows mutations in genes like KRAS, BRAF, and PIK3CA. Testing each mutation separately wastes tissue and time. Clinics needed one combined check.

Their two multiplex assays read twenty-two mutation sites at once. Four genes are covered in the same workflow. Validation showed the combined test catches the key changes reliably. Faster genotyping helps oncologists skip drugs that cannot work for a patient.

Catalog record

CREATORIrene Lurkin, Robert Stoehr, Carolyn D. Hurst et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0008802

Browse the full library · About the Tower of Babel